Recro Pharma Inc (NASDAQ:REPH)

11.27
Delayed Data
As of 4:00pm ET
 -0.41 / -3.51%
Today’s Change
5.81
Today|||52-Week Range
12.23
+21.84%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close11.68
Today’s open11.68
Day’s range11.18 - 11.83
Volume135,095
Average volume (3 months)191,026
Market cap$201.1M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+6.74%
Earnings growth (this year)-43.34%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.60%
P/E ratioNM
Price/Sales2.46
Price/Book6.96

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc+0.02+1.18%
RDHLRedhill Biopharma Lt...-0.21-4.17%
CDMOAvid Bioservices Inc-0.07-1.84%
ACRXAcelRx Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$71.8M
Annual profit (last year)-$50.1M
Net profit margin-69.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Secretary &
Chief Operating Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts